Clinical Trials Browser

Unknown × Lymphoma, B-Cell, Marginal Zone × Antibodies, Monoclonal × Clear all

NCT05073250 2023-05-12

IBI376 Plus Rituximab in Patients With Untreated Indolent Lymphoma.

Phase 2 Unknown

Lymphoma, Follicular, Lymphoma, B-Cell, Marginal Zone